Shekarian Arman, Fakhrolmobasheri Mohammad, Mazaheri-Tehrani Sadegh, Yousefian Amirhossein, Heidarpour Maryam
Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Heart Failure Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Endocrine. 2024 Apr;84(1):29-41. doi: 10.1007/s12020-023-03655-6. Epub 2023 Dec 26.
Subacute thyroiditis (SAT) is a transient inflammatory disorder of the thyroid gland with a possible viral etiology. We conducted this study to estimate the pooled prevalence of thyroid autoantibodies in SAT patients. This question arose due to the varying reports on the positivity rates of thyroid autoantibodies among SAT patients.
We searched PubMed, Embase, Scopus, and Web of Science from their inception until March 25th, 2023. Observational studies reporting the positivity rate of thyroid autoantibodies for more than ten patients were included. We used the Joanna Briggs Institute's (JBI) critical appraisal checklist to assess the quality of the included studies. Pooled prevalence estimates with 95% confidence intervals were calculated using the random effects model. Subgroup analyses were performed to find sources of heterogeneity.
Out of 1373 identified records, 32 studies involving 2348 SAT patients were included in our study. Thyroglobulin antibody (TgAb) and thyroid peroxidase antibody (TPOAb) were positive in 22.8% and 12.2% of patients, respectively. The Study design, mean erythrocyte sedimentation rate and mean thyroid-stimulating hormone of patients were identified as sources of heterogeneity. As our secondary objectives, we found a recurrence rate of 14.7% and permanent hypothyroidism in 11.6% of patients.
The results of our study revealed a low TPOAb positivity rate in SAT patients, consistent with its non-autoimmune etiology. The TgAb positivity rate in SAT patients was higher than that of the general population, possibly explained by the transient release of thyroglobulin into the bloodstream during the thyrotoxic phase, leading to subsequent TgAb production. Furthermore, our findings demonstrate a notable recurrence rate and permanent hypothyroidism among SAT patients, highlighting the importance of ongoing follow-up care.
亚急性甲状腺炎(SAT)是一种甲状腺的短暂性炎症性疾病,可能由病毒引起。我们开展这项研究以估计SAT患者中甲状腺自身抗体的合并患病率。提出这个问题是因为关于SAT患者中甲状腺自身抗体阳性率的报道各不相同。
我们检索了PubMed、Embase、Scopus和Web of Science从创立至2023年3月25日的文献。纳入报告了十名以上患者甲状腺自身抗体阳性率的观察性研究。我们使用乔安娜·布里格斯研究所(JBI)的批判性评价清单来评估纳入研究的质量。使用随机效应模型计算合并患病率估计值及95%置信区间。进行亚组分析以寻找异质性来源。
在1373条识别出的记录中,我们的研究纳入了32项涉及2348例SAT患者的研究。甲状腺球蛋白抗体(TgAb)和甲状腺过氧化物酶抗体(TPOAb)在患者中的阳性率分别为22.8%和12.2%。研究设计、患者的平均红细胞沉降率和平均促甲状腺激素被确定为异质性来源。作为我们的次要目标,我们发现患者的复发率为14.7%,永久性甲状腺功能减退率为11.6%。
我们的研究结果显示SAT患者中TPOAb阳性率较低,与其非自身免疫性病因一致。SAT患者中TgAb阳性率高于一般人群,这可能是由于甲状腺毒症期甲状腺球蛋白短暂释放入血,导致随后产生TgAb。此外,我们的研究结果表明SAT患者中有显著的复发率和永久性甲状腺功能减退,凸显了持续随访护理的重要性。